NL-OMON45627已完成不适用
18F]FB-IL2 PET combined with multi-parametric MRI to analyze treatment-induced changes in tumor microenvironment in advanced cervical cancer - IL2 PET imaging and MRI in T cell respons
Afdeling Gynaecologische Oncologie0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •has signed informed consent
- •histologically confirmed advanced cervical cancer and eligible for chemoradiotherapy
排除标准
- •Pre-existing auto-immune disease
- •The use of corticosteroids (at the start of treatment).
- •Contraindication for MRI (e.g. metallic foreign body, heart pacemaker, severe claustrophobia )
- •eGFR<60 ml/min
研究者
相似试验
进行中（未招募）
1 期
PET/MRI simultaneous imagingJPRN-jRCTs032220546Takahashi Miwako3
招募中
不适用
Simultaneous (18)F-FDG-PET/MRI imaging in diagnostics in case of suspected periprosthetic infection of a total knee or hip replacement.T81.4Infection following a procedure, not elsewhere classifiedDRKS00021211niversitätsklinik Leipzig AöR40
尚未招募
Unknown
Multimodal imaging study using Florzolotau PET and brain MRI for the patients with frontotemporal lobar degeneration and atypical ParkinsonismKCT0008805Gachon University Gil Medical Center120
进行中（未招募）
1 期
Phase II trial: uPAR PET/CT and FDG PET/MRI for determining lymph node metastases in patients with bladder cancerrinary bladder cancerMedDRA version: 19.0Level: LLTClassification code 10005004Term: Bladder cancer NOSSystem Organ Class: 100000004864EUCTR2016-001026-33-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET40
已完成
不适用
Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility StudyIBDNCT02364973Turku University Hospital20